Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and governmental agencies worldwide. It operates through three segments: Wealth Management, Investment Management, and Wholesale. The Wealth Management segment offers various financial products and investment consultation services. The Investment Management segment offers investment trust management, discretionary investment services, and investment funds. The Wholesale segment is involved in the sale, trading, agency execution, and market-making of fixed income and equity products, as well as structured financing and solutions. This segment also engages in underwriting various securities and other financial instruments, such as various classes of shares, convertible and exchangeable securities, investment grade and high yield debts, sovereign and emerging market debts, structured securities, and other securities; arranging private placements, as well as other capital raising activities; and provision of financial advisory services on business transactions comprising mergers and acquisitions, divestitures, spin-offs, capital structuring, corporate defense activities, leveraged buyouts, and risk solutions. The company was formerly known as The Nomura Securities Co., Ltd. and changed its name to Nomura Holdings, Inc. in October 2001. Nomura Holdings, Inc. was incorporated in 1925 and is headquartered in Tokyo, Japan.

Nomura Holdings Inc ADR American Depositary Shares

Neumora Therapeutics, Inc. ( ($NMRA) ) just unveiled an update. On November 17, 2025, Neumora Therapeutics received a conversion notice from K2 Hea...

Neumora Issues Shares Following Loan Conversion Notice

In Q3, Cathie Wood’s ARK Invest significantly boosted its exposure to several Magnificent 7 giants, including Alphabet ($GOOGL), Nvidia ($NVDA), an...

GOOGL, NVDA, TSLA: Cathie Wood’s ARK Invest Loads Up Big on Mag 7 Stocks in Q3

Neumora Therapeutics, Inc. ( ($NMRA) ) has released its Q3 earnings. Here is a breakdown of the information Neumora Therapeutics, Inc. presented to...

Neumora Therapeutics Reports Q3 2025 Progress and Financials

Analysts fell to the sidelines weighing in on Neumora Therapeutics, Inc. (NMRA – Research Report) and Moderna (MRNA – Research Report) with neutral...

Analysts Are Neutral on Top Healthcare Stocks: Neumora Therapeutics, Inc. (NMRA), Moderna (MRNA)

Nova Ltd. ( ($NVMI) ) has released its Q3 earnings. Here is a breakdown of the information Nova Ltd. presented to its investors. Nova Ltd., a leadi...

Nova Ltd. Reports Record Q3 2025 Financial Results

Kepler Capital analyst Emanuele Oggioni maintained a Buy rating on SNAM S.p.A. on November 5 and set a price target of €6.00. The company’s shares ...

Kepler Capital  Sticks to Its Buy Rating for SNAM S.p.A. (0NQP)

Nova ( ($NVMI) ) has shared an update. Nova reported record financial results for the third quarter of 2025, with revenues reaching $224.6 million,...

Nova Achieves Record Third Quarter 2025 Financial Results

In a report released today, Alexander Goldfarb from Piper Sandler maintained a Buy rating on Newmark Group, with a price target of $19.00. The comp...

Newmark Group (NMRK) Gets a Buy from Piper Sandler

The latest announcement is out from Neumora Therapeutics, Inc. ( ($NMRA) ). On October 27, 2025, Neumora Therapeutics announced the initiation of a...

Neumora Therapeutics Begins Phase 1 Study for NMRA-898

Neumora Therapeutics, Inc. ( ($NMRA) ) has provided an update. On October 27, 2025, Neumora Therapeutics announced positive preclinical results for...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NMR	$7.16	+2.58%	2.68M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NMR	$7.16	+2.6%	2.68M
3
4
5
6

NMR

NMR

Get Nomura Holdings Inc ADR American Depositary Shares Data in Excel

Get Nomura Holdings Inc ADR American Depositary Shares Data in Excel